期刊文献+

FUS1和IL-12双基因真核共表达质粒的构建及对A549细胞促凋亡作用研究 被引量:2

Construction and Identification of Eukaryotic Co-expression Plasmid Carrying FUS1 and Recombinant Human IL-12 Genes and Its Effection on Apoptosis of A549 Cells
下载PDF
导出
摘要 目的构建FUS1和人IL-12双基因真核共表达质粒并在肺癌A549细胞中检测基因表达及诱导细胞凋亡作用。方法采用RT-PCR技术从人肺成纤维细胞MRC-5中逆转录扩增全长FUS1基因,通过PCR技术从pORF-hIL-12质粒中扩增含双亚基的全长IL-12基因。FUS1和IL-12分别经酶切后定向插入真核细胞双顺反子载体pVITRO2的多克隆位点中,酶切和测序鉴定双基因共表达质粒pVITRO2-FUS1-IL-12的构建。以pVITRO2-FUS1-IL-12转染肺癌A549细胞,通过RT-PCR、ELISA和Western blot方法检测目的基因的表达,以Hoechst33258染色及流式细胞术验证pVITRO2-FUS1-IL-12在体外的促凋亡作用。结果酶切和测序分析表明成功构建了双基因真核共表达质粒pVITRO2-FUS1-IL-12,在转染后的细胞中同时检测到了FUS1和IL-12的表达,两种基因在双基因表达载体上的表达量基本不受影响。双基因共表达质粒pVITRO2-FUS1-IL-12具有明显诱导肺癌细胞凋亡的作用。结论成功构建pVITRO2-FUS1-IL-12双基因真核共表达质粒,为肺癌的多基因联合治疗提供了又一新的思路和方法。 Objective To construct a eukaryotic co-expression plasmid containing FUS1 and IL-12, and to investigate the influence of the recombinant plasmid on the cultured human lung cancer cell line A549. Methods RT-PCR was applied to ampIify FUS1 from MRC-5 cell, the eDNA fragment of IL-12 was derived from pORF-hIL- 12 by PCR, FUS1 cDNA fragment and IL-12 cDNA fragment were inserted into the multiple cloning sites of pVITRO2 to generate the eukaryotic co-expression plasmid pVITRO2-FUS1-IL-12. The recombinant plasmid was confirmed by restriction endonuclease treatment and sequenceing and transfected into A549 cells. The expression of genes in pVITRO2-FUSI-IL-12 were identified by RT-PCR, ELISA and Western blot. The function of pVITRO2- FUS1-IL-12 inducing the apoptosis of lung cancer was identified by Hoechst33258 and flow cytometry. Results The restriction cndonuclease digestion and sequencing suggested that co-expression vector pVITRO2-FUS1-IL-12 was constructed successfully, the expression of FUS1 and IL-12 could be detected in A549 cells. The expressions of the two genes in pVITRO2 were not affected. The A549 cells transfected with pVITRO2-FUS1-IL-12 exhibited significant cell apoptosis. Conclusion The recombinant eukaryotie expression vector pVITRO2-FUS1-IL-12 was constructed and expressed in eukaryotic ceil successfully, which would contribute to a novel and effective treatment strategies for combined gene therapy for lung cancer.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2009年第4期569-574,共6页 Journal of Sichuan University(Medical Sciences)
基金 重大新药创制"科技重大专项基金(2009ZX09301)资助
关键词 肺癌 FUS1 IL-12 真核共表达载体 联合基因治疗 Lung cancer FUS1 IL-12 Eukaryotic co-expression vector Combined gene therapy
  • 相关文献

参考文献16

  • 1Prudkin L,Behrens C,Liu DD,et al.Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer.Clin Cancer Res,2008;14(1):41-47.
  • 2Uno F,Sasaki J,Nishizaki M,et al.Myristoylation of the fus1protein is required for tumor suppression in human lung cancer cells.Cancer Res,2004;64(9):2969-2976.
  • 3Matsunaga K,Yamaguchi H,Klein TW,et al.Legionella pneumophila suppresses macrophage interleukin-12 production by activating the p42/44 mitogen-activated protein kinase cascade.Infect Immun,2003;71(11):6672-6675.
  • 4Andrew KJ,Ribas A,Bufferfield LH,et al.Adenvirus-interleulin-12 mediated tumor regression in murine hepatocelluar carcinoma model is not depended on CD1 restricted natural killer T cell.Cancer Res,2000;60(22):6457-6464.
  • 5Sangro B,Melero I,Qian C,et al.Gene therapy of cancer based on interleukin 12.Current Gene Therapy,2005;5(6):573-581.
  • 6Gollob JA,Mier JW,Veenstra K,et al.Phase Ⅰ Trial of Twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma:ability to maintain IFN-γ induction is associated with clinical response.Clin Cancer Res,2000;6(5):1678-1692.
  • 7Chen B,Timiryasova TM,Andres ML,et al.Evaluation of combined vaccinia virus mediated antitumor gene therapy with p53,IL-2,and IL-12 in a glioma model.Cancer Gene Ther,2000;7(11):1678-1692.
  • 8Ji L,Roth JA.Tumor suppressor FUS1 signaling pathway.J Thorac Oncol,2008;3(4):327-330.
  • 9Kondo M,Ji L,Kamibayashi C,et al.Over expression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.Oncogene,2001;20(43):6258-6262.
  • 10Tanaka M,Saijo Y,Sato G,et al.Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.Cancer Gene Ther,2000;7(11):1481-1490.

同被引文献21

  • 1卓文磊,王彦,陈正堂.CD44v3短发夹RNA对透明质酸诱导人结肠癌SW480细胞体外粘附和侵袭的抑制作用[J].中国癌症杂志,2005,15(6):518-521. 被引量:6
  • 2KONDO M, JI L, KAMIBAYASHI C, et al. Overexpression of candidate tumor suppressor gene fusl isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells[J]. Oncogene, 2001,20 (43) :6258-6262.
  • 3LIN J, MASAHIKO N, BONING G, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo[J]. Cancer Res,2002,62 (9) :2715- 2720.
  • 4MATSUNAGA K, YAMAGUCHI H, KLEIN T W, et al. Legionella pneumophila suppresses macrophage interleukin-12 production by activating the p42/44 mitogen-activated protein kinase cascade[J]. Infect Immun, 2003,71 (11) :6672-6675.
  • 5BRUNO S, IGNACIO M, CHENG Q,et al. Gene Therapy of Cancer Based on Interleukin 12[J]. Current Gene Therapy, 2005,5(6) :573-581.
  • 6EWERT K K, AHMAD A, BOUXSEIN N F, et al. Nov-viral gene delivery with cationic liposome-DNA complex[J]. Methods Mol Biol, 2008,433 : 159-175.
  • 7ITO I, BEGAN G, MOHIUDDIN I, SAEKI T, et al. Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration[J]. Mol Ther, 2003, 7(3) :409-418.
  • 8POULSEN T T,PEDERSEN N, POULSEN H S. Replacement and suicide genetherapy for targeted treatment of lung cancer[J]. Clin Lung Cancer, 2005,6 (4):227-236.
  • 9HOOD J D,BEDNARSKI M,FRAUSTO R,et al. Tumor regression by targeted gene delivery to the neovasculature[J]. Science, 2002,296(5577):2404-2407.
  • 10KIM Y J,K IM T W, CHUNG H, et al. The effects of serumon the stability and the transfection activity of the cationic lipid emulsion with various oils[J]. Int J Pharm,2003,252 (1- 2) :241-252.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部